1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Roesch, P.
Marx, U.C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H6 O4
118.088
SUCCINIC ACID
non-polymer
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
Bayreuth : University of Bayreuth (Thesis)
GW
Strukturen Verschiedener Parathormonfragmente in Loesung
2123
-1
1996
10.2210/pdb1zwg/pdb
pdb_00001zwg
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4235.930
PARATHYROID HORMONE
4 - 37
N-TERMINAL SUCCINYLATED
1
man
polymer
N-SUCCINYL-HPTH(4-37)
no
yes
(SIN)EIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL
XEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
POTENTIAL
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-06-16
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_conn.pdbx_leaving_atom_flag
Y
BNL
1996-06-17
REL
10
BRUNGER
refinement
X-PLOR
3.1
SIN
1
n
1
SIN
1
A
GLU
2
n
2
GLU
2
A
ILE
3
n
3
ILE
3
A
GLN
4
n
4
GLN
4
A
LEU
5
n
5
LEU
5
A
MET
6
n
6
MET
6
A
HIS
7
n
7
HIS
7
A
ASN
8
n
8
ASN
8
A
LEU
9
n
9
LEU
9
A
GLY
10
n
10
GLY
10
A
LYS
11
n
11
LYS
11
A
HIS
12
n
12
HIS
12
A
LEU
13
n
13
LEU
13
A
ASN
14
n
14
ASN
14
A
SER
15
n
15
SER
15
A
MET
16
n
16
MET
16
A
GLU
17
n
17
GLU
17
A
ARG
18
n
18
ARG
18
A
VAL
19
n
19
VAL
19
A
GLU
20
n
20
GLU
20
A
TRP
21
n
21
TRP
21
A
LEU
22
n
22
LEU
22
A
ARG
23
n
23
ARG
23
A
LYS
24
n
24
LYS
24
A
LYS
25
n
25
LYS
25
A
LEU
26
n
26
LEU
26
A
GLN
27
n
27
GLN
27
A
ASP
28
n
28
ASP
28
A
VAL
29
n
29
VAL
29
A
HIS
30
n
30
HIS
30
A
ASN
31
n
31
ASN
31
A
PHE
32
n
32
PHE
32
A
VAL
33
n
33
VAL
33
A
ALA
34
n
34
ALA
34
A
LEU
35
n
35
LEU
35
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
18
0.317
SIDE CHAIN
1
A
ARG
23
0.317
SIDE CHAIN
2
A
ARG
18
0.317
SIDE CHAIN
2
A
ARG
23
0.316
SIDE CHAIN
3
A
ARG
18
0.314
SIDE CHAIN
3
A
ARG
23
0.316
SIDE CHAIN
4
A
ARG
18
0.295
SIDE CHAIN
4
A
ARG
23
0.305
SIDE CHAIN
5
A
ARG
18
0.236
SIDE CHAIN
5
A
ARG
23
0.307
SIDE CHAIN
6
A
ARG
18
0.316
SIDE CHAIN
6
A
ARG
23
0.316
SIDE CHAIN
7
A
ARG
18
0.312
SIDE CHAIN
7
A
ARG
23
0.307
SIDE CHAIN
8
A
ARG
18
0.317
SIDE CHAIN
8
A
ARG
23
0.303
SIDE CHAIN
9
A
ARG
18
0.315
SIDE CHAIN
9
A
ARG
23
0.315
SIDE CHAIN
10
A
ARG
18
0.302
SIDE CHAIN
10
A
ARG
23
0.317
SIDE CHAIN
1
A
ILE
3
-122.81
-55.08
1
A
HIS
12
-81.22
-93.24
1
A
LEU
13
50.31
-155.11
1
A
ASN
14
-164.52
79.17
1
A
SER
15
52.00
-78.12
1
A
ASN
31
-179.45
-52.17
1
A
VAL
33
171.84
90.46
1
A
ALA
34
-176.57
-71.49
2
A
ASN
14
-172.31
-41.10
2
A
SER
15
-139.25
-72.33
2
A
GLN
27
-95.95
33.42
2
A
HIS
30
-44.11
92.55
2
A
ASN
31
76.66
-65.62
2
A
PHE
32
-180.00
-94.77
2
A
VAL
33
24.18
48.36
2
A
ALA
34
-149.35
23.20
3
A
HIS
12
27.00
63.98
3
A
ASN
14
130.31
161.86
3
A
HIS
30
-97.13
50.03
3
A
ASN
31
-156.90
-49.28
3
A
PHE
32
-67.08
81.00
4
A
ASN
8
-80.53
41.35
4
A
LYS
11
87.20
-61.65
4
A
HIS
12
153.83
-21.37
4
A
LEU
13
33.21
-154.57
4
A
ASN
14
-172.03
-47.80
4
A
SER
15
-144.85
-78.91
4
A
GLN
27
-97.77
-79.16
4
A
ASP
28
65.32
-71.62
4
A
PHE
32
-99.33
38.17
4
A
VAL
33
74.08
-63.60
4
A
ALA
34
77.57
-62.51
5
A
LEU
13
-129.75
-90.80
5
A
ASN
14
175.76
-86.62
5
A
SER
15
-161.14
-60.57
5
A
GLN
27
-102.73
44.35
5
A
VAL
29
-99.75
48.87
5
A
HIS
30
-141.17
-52.69
5
A
VAL
33
69.28
80.94
6
A
LEU
13
-132.90
-56.06
6
A
ASN
14
176.34
160.95
6
A
GLN
27
-89.77
-77.38
6
A
VAL
29
-178.89
-47.56
6
A
PHE
32
-166.46
-142.06
7
A
LEU
13
22.25
-100.80
7
A
ASN
14
-164.09
-80.07
7
A
SER
15
-146.04
-66.61
7
A
GLN
27
-96.94
42.03
7
A
HIS
30
-20.18
-51.51
7
A
ASN
31
-156.00
27.09
7
A
PHE
32
44.47
94.65
7
A
VAL
33
37.41
52.64
7
A
ALA
34
-128.30
-153.05
8
A
ASN
8
-86.88
38.11
8
A
LEU
9
-130.38
-63.28
8
A
ASN
14
176.76
151.87
8
A
SER
15
44.09
-83.83
8
A
GLN
27
-91.81
59.61
8
A
HIS
30
15.38
-102.12
8
A
PHE
32
146.42
-32.10
8
A
VAL
33
-55.85
89.12
9
A
ASN
14
178.92
-46.12
9
A
SER
15
-135.74
-81.10
9
A
GLN
27
-82.00
-96.42
9
A
ASP
28
68.29
-59.54
9
A
HIS
30
-21.76
-51.11
9
A
ASN
31
-143.47
12.06
9
A
PHE
32
47.31
86.65
9
A
ALA
34
-126.45
-62.99
10
A
GLN
4
77.76
-58.02
10
A
LEU
9
-109.65
-68.25
10
A
GLN
27
-69.64
-76.61
10
A
ASP
28
42.45
85.05
10
A
VAL
29
82.96
-51.86
10
A
HIS
30
28.68
82.36
10
A
ASN
31
76.74
-52.13
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
SUCCINYL HUMAN PARATHYROID HORMONE 4-37, NMR, 10 STRUCTURES
1
Y
N
A
ILE
3
A
ILE
3
HELX_P
A
GLY
10
A
GLY
10
1
1
8
A
MET
16
A
MET
16
HELX_P
A
LEU
26
A
LEU
26
1
2
11
covale
1.325
both
A
SIN
1
A
C4
SIN
1
1_555
A
GLU
2
A
N
GLU
2
1_555
HORMONE
HORMONE, DISEASE MUTATION
PTHY_HUMAN
UNP
1
1
P01270
MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQ
RPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ
35
68
1ZWG
2
35
P01270
A
1
2
35
1
P 1